Trichlorethanol

Trichlorethanol

SCHEMBL1065673

O.OCC(Cl)(Cl)Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Trichlorethanol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8648180-B2 Compound Smilaxchinoside F Guilin Sanjin Pharmaceuticals Co., Ltd. (CN) 2014-02-11 US claimed
US-20130090461-A1 NEW COMPOUND SMILAXCHINOSIDE F GUILIN SANJIN PHARMACEUTICAL CO., LTD. (CN) 2013-04-11 US claimed
CN-116789662-A Method for separating and purifying alkaloid compounds in phellodendron amurense by high-speed countercurrent chromatography 山东省分析测试中心 2023-09-22 CN disclosed
US-20230074255-A1 STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF PROTALIX LTD. (IL) 2023-03-09 US disclosed
US-10870842-B2 Stabilized alpha-galactosidase and uses thereof PROTALIX LTD. (IL) 2020-12-22 US disclosed
EP-3018125-B1 NOVEL COMPOUND, ORGANIC CATION TRANSPORTER 3 DETECTION AGENT, AND ORGANIC CATION TRANSPORTER 3 ACTIVITY INHIBITOR SHIN NIPPON BIOMEDICAL LABORATORIES LTD (JP) 2020-08-05 EP disclosed
EP-3616705-A2 COMPOSITION FOR IMPROVING PREVENTION AND TREATMENT OF FATTY LIVER CONTAININGAMOMUM VILOSUM Corporation Ilwonbio (KR) 2020-03-04 EP disclosed
US-20190321381-A1 COMPOSITION COMPRISING SEA CUCUMBER EXTRACT AS EFFECTIVE INGREDIENT FOR PREVENTING AND TREATING BRUCH'S MEMBRANE DYSFUNCTION-RELATED DISEASE ALTREGEN CO., LTD. (KR) 2019-10-24 US disclosed
EP-3556373-A1 COMPOSITION COMPRISING SEA CUCUMBER EXTRACT AS EFFECTIVE INGREDIENT FOR PREVENTING AND TREATING BRUCH'S MEMBRANE DYSFUNCTION-RELATED DISEASE Altregen Co., Ltd. (KR) 2019-10-23 EP disclosed
US-20190256832-A1 STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF PROTALIX LTD. (IL) 2019-08-22 US disclosed
US-10280414-B2 Stabilized α-galactosidase and uses thereof PROTALIX LTD. (IL) 2019-05-07 US disclosed
EP-0552489-B1 Peptide, production and use thereof TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1998-03-04 EP disclosed
WO-1997046671-A1 ENHANCED EFFICACY OF LIPOSOMAL ANTISENSE DELIVERY UNIVERSITY OF BRITISH COLUMBIA (CA) 1997-12-11 WO disclosed
EP-0711782-A1 A method of preparing ganglioside SNOW BRAND MILK PRODUCTS CO., LTD. (JP) 1996-05-15 EP disclosed
EP-0657471-A1 Anti ganglioside monoclonal antibodies and their use in the specific active immunotherapy of malignant tumours Centro de Inmunologia Molecular (CU) 1995-06-14 EP disclosed
EP-0552489-A2 Peptide, production and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-07-28 EP disclosed
WO-1990003184-A1 MATRIX WITH IMMUNOMODULATING ACTIVITY MOREIN BROR (SE) 1990-04-05 WO disclosed
EP-0275270-A1 METHOD FOR THE RADIOIODATION OF GANGLIOSIDES BY ENZYMATIC PROCESS. CENTRE NAT RECH SCIENT (FR) 1988-07-27 EP disclosed
WO-1988000175-A1 METHOD FOR THE RADIOIODATION OF GANGLIOSIDES BY ENZYMATIC PROCESS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS (FR) 1988-01-14 WO disclosed
US-3981927-A INHALATION ANESTHETICS HOECHST AKTIENGESELLSCHAFT (DT) 1976-09-21 US disclosed